An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Summary

The bill adds a definition of “opioid antagonist” to the state Controlled Substance Act, specifying that it includes FDA‑approved drugs like naloxone and nalmefene used to reverse opioid overdoses. The change clarifies the terminology for regulators, courts, and health officials. It takes effect 60 days after enactment.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share